EcoDrugPlus

Thyroid Hormone Receptor Beta

Ensembl ID : ENSCSEG00000010308
Gene Symbol: THRB
3 Cross references
390 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSCSEG00000009311
Gene Symbol: TRHR
3 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSCSEG00000009016
Gene Symbol: LOC103393929
3 Cross references
194 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSCSEG00000021236
Gene Symbol: LOC103396647
2 Cross references
171 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSCSEG00000010063
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSCSEG00000010065
Gene Symbol: TLR8
2 Cross references
185 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCSEG00000011738
Gene Symbol: TAAR1
3 Cross references
401 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCSEG00000011746
Gene Symbol: TAAR1
1 Cross references
401 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSCSEG00000011756
Gene Symbol: TAAR1
1 Cross references
401 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSCSEG00000007045
Gene Symbol: LOC103399273
2 Cross references
381 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCSEG00000009934
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Transmembrane O-Methyltransferase Homolog

Ensembl ID : ENSCSEG00000004563
Gene Symbol: LOC103390712
2 Cross references
177 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).